Nicola Burgess-Brown

Dr. Nicola Burgess-Brown


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Journal of Structural Biology
Verified
Journal Article
Open access
PSPavel Savitsky
Pavel Savitsky
JBJames Bray
James Bray
CCChristopher Cooper
Christopher Cooper
BMBrian D. Marsden
Brian D. Marsden
PMPravin Mahajan
Pravin Mahajan
OGOpher Gileadi
Opher Gileadi
Producing purified human proteins with high yield and purity remains a considerable challenge. We describe the methods utilized in the Structural Genomics Consortium (SGC) in Oxford, resulting in successful purification of 48% of human proteins attempted; of those, the structures of approximately 40% were solved by X-ray crystallography. The main driver has been the parallel processing of multiple (typically 9-20) truncated constructs of each target; modest diversity in vectors and host systems; and standardized purification procedures. We provide method details as well as data on the properties of the constructs leading to crystallized proteins and the impact of methodological variants. These can be used to formulate guidelines for initial approaches to expression of new eukaryotic proteins.

13 July 2014 in Epigenetics & Chromatin
Verified
Journal Article
Open access
PDF file
MPMartin Philpott
Martin Philpott
CRCatherine M Rogers
Catherine M Rogers
CYClarence Yapp
Clarence Yapp
CWChris Wells
Chris Wells
JLJean-Philippe Lambert
Jean-Philippe Lambert
SMSusanne Müller
Susanne Müller
Acetylation of lysine residues in histone tails plays an important role in the regulation of gene transcription. Bromdomains are the readers of acetylated histone marks, and, consequently, bromodomain-containing proteins have a variety of chromatin-related functions. Moreover, they are increasingly being recognised as important mediators of a wide range of diseases. The first potent and selective bromodomain inhibitors are beginning to be described, but the diverse or unknown functions of bromodomain-containing proteins present challenges to systematically demonstrating cellular efficacy and selectivity for these inhibitors. Here we assess the viability of fluorescence recovery after photobleaching (FRAP) assays as a target agnostic method for the direct visualisation of an on-target effect of bromodomain inhibitors in living cells.

1 March 2018 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DBD. Bulbrook
D. Bulbrook
HBH. Brazier
H. Brazier
PMP. Mahajan
P. Mahajan
MKM. Kliszczak
M. Kliszczak
OFO. Fedorov
O. Fedorov
JDJ.L.E. Dean
J.L.E. Dean

1 November 2021 in Structure
Verified
Journal Article
Open access
ASAleksandra Szykowska
Aleksandra Szykowska
YCYu Chen
Yu Chen
TSThomas B. Smith
Thomas B. Smith
CPCharlotta Preger
Charlotta Preger
JYJingjing Yang
Jingjing Yang
ABAlex Bullock
Alex Bullock
Mutations in TREM2, a receptor expressed by microglia in the brain, are associated with an increased risk of neurodegeneration, including Alzheimer's disease. Numerous studies support a role for TREM2 in sensing damaging stimuli and triggering signaling cascades necessary for neuroprotection. Despite its significant role, ligands and regulators of TREM2 activation, and the mechanisms governing TREM2-dependent responses and its cleavage from the membrane, remain poorly characterized. Here, we present phage display generated antibody single-chain variable fragments (scFvs) to human TREM2 immunoglobulin-like domain. Co-crystal structures revealed the binding of two scFvs to an epitope on the TREM2 domain distal to the putative ligand-binding site. Enhanced functional activity was observed for oligomeric scFv species, which inhibited the production of soluble TREM2 in a HEK293 cell model. We hope that detailed characterization of their epitopes and properties will facilitate the use of these renewable binders as structural and functional biology tools for TREM2 research.

31 October 2020
Verified
Book Chapter
Closed access
PDF file
PMPravin Mahajan
Pravin Mahajan
KEKatherine Ellis
Katherine Ellis
SMShubhashish Mukhopadhyay
Shubhashish Mukhopadhyay
AFAlejandra Fernandez-Cid
Alejandra Fernandez-Cid
GCGamma Chi
Gamma Chi
NBNicola Burgess-Brown
Nicola Burgess-Brown

19 October 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
SBSimon R. Bushell
Simon R. Bushell
APAshley C.W. Pike
Ashley C.W. Pike
MFMaria E. Falzone
Maria E. Falzone
NRNils J. G. Rorsman
Nils J. G. Rorsman
CTChau M Ta
Chau M Ta
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
Membranes in cells have defined distributions of lipids in each leaflet, controlled by lipid scramblases and flip/floppases. However, for some intracellular membranes such as the endoplasmic reticulum the scramblases have not been identified. Members of the TMEM16 family have either lipid scramblase and ion channel activity, or specific chloride channel activity. Although TMEM16K is widely distributed and associated with the neurological disorder autosomal recessive spinocerebellar ataxia type 10 (SCAR10), its location in cells, function and structure are largely uncharacterised. Here we show that TMEM16K is an ER-resident calcium-regulated lipid scramblase. Our crystal structures of TMEM16K show a scramblase fold, with an open lipid transporting groove. Additional structures solved by cryo-EM reveal extensive conformational changes extending from the cytoplasmic to the ER side of the membrane, giving a state with a closed lipid permeation pathway. Molecular dynamics simulations showed that the open-groove conformation is necessary for scramblase activity. Our results suggest mechanisms by which missense variants of TMEM16K could cause SCAR10 ataxia, providing new hypotheses to explore for therapy.